Dionson, Analiza L.
HRN: 26-98-10 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/05/2025
CEFUROXIME 500MG (TAB)
05/05/2025
05/11/2025
ORAL
500mg
2 Times A Day
NSVD With RMLE, Thinly MSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes